Malignant Graves' Orbitopathy Complicated by Endophthalmitis, Vision Loss, and Antithyroid Drug- Induced Agranulocytosis: A Case Report

Introduction Severe forms of Graves' orbitopathy (GO) account for only a minority of cases, delayed diagnosis and management may result in sight-threatening complications, including orbital infection, and irreversible vision loss. Herein we report a case of a 77-year-old woman with severe GO complicated with endophtalmitis and anti-thyroid drug (ATD) induced agranulocytosis. Case Presentation A 77-year-old woman was referred for evaluation and management of Graves' disease associated with severe GO. Seven months before presentation, she developed progressive left-sided proptosis, conjunctival hyperemia and ocular pruritus. Initial ophthalmological management was limited to lubricating eye drops. Over the following months, her condition deteriorated with ocular pain, complete restriction of left ocular motility, and marked visual impairment. Hyperthyroidism was confirmed. Ophthalmological examination demonstrated a left corneal abscess complicated by corneal perforation sealed by iris prolapse, circumferential corneal neovascularization, ocular hypertension, and no light perception. Hyperthyroidism was initially treated with carbimazole and propranolol. One month later, the patient developed severe ATD-induced agranulocytosis with erythroderma, fever, and acute kidney injury, requiring immediate discontinuation of antithyroid therapy. Following stabilization, Lugol's iodine was administered before total thyroidectomy. Management of the orbitopathy included tarsorrhaphy, prolonged intravenous antibiotic therapy, intravenous methylprednisolone, and mycophenolate mofetil. Despite successful control of the infectious and inflammatory process, irreversible vision loss occurred, ultimately necessitating enucleation of the left eye. Conclusion This case highlights the devastating consequences of delayed diagnosis and treatment of Graves' orbitopathy, which may progress to irreversible blindness. It also illustrates the potential impact of antithyroid drug-induced agranulocytosis on the development of infectious complications.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11393472/v1
Primary Topic
Ophthalmology and Eye Disorders
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Malignant Graves' Orbitopathy Complicated by Endophthalmitis, Vision Loss, and Antithyroid Drug- Induced Agranulocytosis: A Case Report

Najla Bchir, Chedia Zouaoui, Anaam Ben Chehida, H. Ouertani et al.
Research Square
Ophthalmology and Eye Disorders
preprint

Malignant Graves' Orbitopathy Complicated by Endophthalmitis, Vision Loss, and Antithyroid Drug- Induced Agranulocytosis: A Case Report

Najla Bchir, Chedia Zouaoui, Anaam Ben Chehida, H. Ouertani, Mariam Mabrouk, Sakr Bouchoucha, Slaheddine Mnasriya, Dorra Elguiche
preprint en

Abstract

Introduction Severe forms of Graves' orbitopathy (GO) account for only a minority of cases, delayed diagnosis and management may result in sight-threatening complications, including orbital infection, and irreversible vision loss. Herein we report a case of a 77-year-old woman with severe GO complicated with endophtalmitis and anti-thyroid drug (ATD) induced agranulocytosis. Case Presentation A 77-year-old woman was referred for evaluation and management of Graves' disease associated with severe GO. Seven months before presentation, she developed progressive left-sided proptosis, conjunctival hyperemia and ocular pruritus. Initial ophthalmological management was limited to lubricating eye drops. Over the following months, her condition deteriorated with ocular pain, complete restriction of left ocular motility, and marked visual impairment. Hyperthyroidism was confirmed. Ophthalmological examination demonstrated a left corneal abscess complicated by corneal perforation sealed by iris prolapse, circumferential corneal neovascularization, ocular hypertension, and no light perception. Hyperthyroidism was initially treated with carbimazole and propranolol. One month later, the patient developed severe ATD-induced agranulocytosis with erythroderma, fever, and acute kidney injury, requiring immediate discontinuation of antithyroid therapy. Following stabilization, Lugol's iodine was administered before total thyroidectomy. Management of the orbitopathy included tarsorrhaphy, prolonged intravenous antibiotic therapy, intravenous methylprednisolone, and mycophenolate mofetil. Despite successful control of the infectious and inflammatory process, irreversible vision loss occurred, ultimately necessitating enucleation of the left eye. Conclusion This case highlights the devastating consequences of delayed diagnosis and treatment of Graves' orbitopathy, which may progress to irreversible blindness. It also illustrates the potential impact of antithyroid drug-induced agranulocytosis on the development of infectious complications.

Research Square
Military Hospital of Tunis (TN)
Ophthalmology and Eye Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon